Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Statistics

Total Valuation

VRTX has a market cap or net worth of $104.81 billion. The enterprise value is $95.35 billion.

Market Cap	104.81B
Enterprise Value	95.35B

Important Dates

The next estimated earnings date is Monday, February 3, 2025, after market close.

Earnings Date	Feb 3, 2025
Ex-Dividend Date	n/a

Share Statistics

VRTX has 257.53 million shares outstanding. The number of shares has decreased by -0.91% in one year.

Current Share Class	257.53M
Shares Outstanding	257.53M
Shares Change (YoY)	-0.91%
Shares Change (QoQ)	+1.12%
Owned by Insiders (%)	0.18%
Owned by Institutions (%)	93.67%
Float	256.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	23.11
PS Ratio	9.97
Forward PS	9.05
PB Ratio	6.77
P/TBV Ratio	7.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.23

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.97
EV / EBITDA	21.44
EV / EBIT	22.50
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.11.

Current Ratio	2.47
Quick Ratio	2.08
Debt / Equity	0.11
Debt / EBITDA	0.39
Debt / FCF	n/a
Interest Coverage	110.38

Financial Efficiency

Return on equity (ROE) is -2.99% and return on invested capital (ROIC) is 15.29%.

Return on Equity (ROE)	-2.99%
Return on Assets (ROA)	12.05%
Return on Capital (ROIC)	15.29%
Revenue Per Employee	$1.97M
Profits Per Employee	-$88,852
Employee Count	5,400
Asset Turnover	0.48
Inventory Turnover	5.58

Taxes

In the past 12 months, VRTX has paid $739.40 million in taxes.

Income Tax	739.40M
Effective Tax Rate	284.82%

Stock Price Statistics

The stock price has increased by +0.12% in the last 52 weeks. The beta is 0.37, so VRTX's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	+0.12%
50-Day Moving Average	464.66
200-Day Moving Average	457.54
Relative Strength Index (RSI)	31.52
Average Volume (20 Days)	1,781,394

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, VRTX had revenue of $10.63 billion and -$479.80 million in losses. Loss per share was -$1.86.

Revenue	10.63B
Gross Profit	5.69B
Operating Income	4.24B
Pretax Income	214.70M
Net Income	-479.80M
EBITDA	4.45B
EBIT	4.24B
Loss Per Share	-$1.86

Balance Sheet

The company has $6.52 billion in cash and $1.77 billion in debt, giving a net cash position of $9.45 billion or $36.71 per share.

Cash & Cash Equivalents	6.52B
Total Debt	1.77B
Net Cash	9.45B
Net Cash Per Share	$36.71
Equity (Book Value)	15.63B
Book Value Per Share	60.65
Working Capital	5.83B

Cash Flow

In the last 12 months, operating cash flow was -$842.60 million and capital expenditures -$263.20 million, giving a free cash flow of -$1.11 billion.

Operating Cash Flow	-842.60M
Capital Expenditures	-263.20M
Free Cash Flow	-1.11B
FCF Per Share	-$4.29

Margins

Gross margin is 53.59%, with operating and profit margins of 39.89% and -4.52%.

Gross Margin	53.59%
Operating Margin	39.89%
Pretax Margin	2.44%
Profit Margin	-4.52%
EBITDA Margin	41.85%
EBIT Margin	39.89%
FCF Margin	n/a

Dividends & Yields

VRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.91%
Shareholder Yield	0.91%
Earnings Yield	-0.46%
FCF Yield	-1.06%

Analyst Forecast

The average price target for VRTX is $507.72, which is 24.76% higher than the current price. The consensus rating is "Buy".

Price Target	$507.72
Price Target Difference	24.76%
Analyst Consensus	Buy
Analyst Count	30
Revenue Growth Forecast (5Y)	9.84%
EPS Growth Forecast (5Y)	13.55%

Stock Splits

The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.

Last Split Date	Aug 24, 2000
Split Type	Forward
Split Ratio	2:1

Scores

VRTX has an Altman Z-Score of 11.97 and a Piotroski F-Score of 1.

Altman Z-Score	11.97
Piotroski F-Score	1